BioRem Inc. (BRM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioRem Inc. (BRM) has a cash flow conversion efficiency ratio of -0.160x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.82 Million ≈ $-2.04 Million USD) by net assets (CA$17.59 Million ≈ $12.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is BioRem Inc. worth for the company's overall valuation and market capitalisation.
BioRem Inc. - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how BioRem Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
BioRem Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioRem Inc. ranked by their cash flow conversion efficiency. Explore cash flow quality index of BioRem Inc. to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Granprade
JSE:GPL
|
-0.020x |
|
Altustfi
WAR:ALI
|
0.034x |
|
George Kent (Malaysia) Bhd
KLSE:3204
|
-0.045x |
|
APS Energia S.A.
WAR:APE
|
0.080x |
|
Wijaya Karya Beton
JK:WTON
|
0.038x |
|
Huneed Tech
KO:005870
|
-0.041x |
|
TradeDoubler AB
ST:TRAD
|
0.041x |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
-0.169x |
Annual Cash Flow Conversion Efficiency for BioRem Inc. (2003–2025)
The table below shows the annual cash flow conversion efficiency of BioRem Inc. from 2003 to 2025. View BioRem Inc. stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$14.93 Million ≈ $10.80 Million |
CA$7.64 Million ≈ $5.53 Million |
0.512x | +47.56% |
| 2024-12-31 | CA$10.63 Million ≈ $7.69 Million |
CA$3.69 Million ≈ $2.67 Million |
0.347x | +375.61% |
| 2023-12-31 | CA$6.72 Million ≈ $4.86 Million |
CA$490.03K ≈ $354.48K |
0.073x | -77.19% |
| 2022-12-31 | CA$4.52 Million ≈ $3.27 Million |
CA$1.44 Million ≈ $1.05 Million |
0.320x | -83.40% |
| 2021-12-31 | CA$1.96 Million ≈ $1.42 Million |
CA$3.78 Million ≈ $2.74 Million |
1.925x | +680.67% |
| 2020-12-31 | CA$13.52 Million ≈ $9.78 Million |
CA$3.34 Million ≈ $2.41 Million |
0.247x | +14.39% |
| 2019-12-31 | CA$11.72 Million ≈ $8.48 Million |
CA$2.53 Million ≈ $1.83 Million |
0.216x | +110161.99% |
| 2018-12-31 | CA$12.90 Million ≈ $9.33 Million |
CA$-2.53K ≈ $-1.83K |
0.000x | -100.12% |
| 2017-12-31 | CA$7.30 Million ≈ $5.28 Million |
CA$1.17 Million ≈ $848.71K |
0.161x | +150.15% |
| 2016-12-31 | CA$2.43 Million ≈ $1.76 Million |
CA$-777.78K ≈ $-562.63K |
-0.320x | -128.83% |
| 2015-12-31 | CA$1.93 Million ≈ $1.40 Million |
CA$2.15 Million ≈ $1.55 Million |
1.112x | -35.61% |
| 2014-12-31 | CA$-258.09K ≈ $-186.70K |
CA$-445.59K ≈ $-322.34K |
1.727x | +108.19% |
| 2013-12-31 | CA$884.72K ≈ $639.99K |
CA$733.71K ≈ $530.75K |
0.829x | +108.54% |
| 2012-12-31 | CA$54.63K ≈ $39.52K |
CA$-530.21K ≈ $-383.54K |
-9.706x | -774.52% |
| 2011-12-31 | CA$629.11K ≈ $455.09K |
CA$905.26K ≈ $654.85K |
1.439x | +533.27% |
| 2010-12-31 | CA$5.59 Million ≈ $4.05 Million |
CA$-1.86 Million ≈ $-1.34 Million |
-0.332x | -233.70% |
| 2009-12-31 | CA$8.55 Million ≈ $6.18 Million |
CA$2.12 Million ≈ $1.54 Million |
0.248x | +182.15% |
| 2008-12-31 | CA$8.79 Million ≈ $6.36 Million |
CA$-2.66 Million ≈ $-1.92 Million |
-0.302x | -24.45% |
| 2007-12-31 | CA$8.52 Million ≈ $6.16 Million |
CA$-2.07 Million ≈ $-1.50 Million |
-0.243x | -339.10% |
| 2006-12-31 | CA$11.33 Million ≈ $8.20 Million |
CA$1.15 Million ≈ $832.95K |
0.102x | +163.83% |
| 2005-12-31 | CA$8.63 Million ≈ $6.25 Million |
CA$-1.37 Million ≈ $-994.47K |
-0.159x | -161.68% |
| 2004-12-31 | CA$384.55K ≈ $278.18K |
CA$-23.40K ≈ $-16.93K |
-0.061x | -120.61% |
| 2003-12-31 | CA$-968.76K ≈ $-700.79K |
CA$-285.98K ≈ $-206.87K |
0.295x | -- |
About BioRem Inc.
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It a… Read more